Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(±)-ML 209 is a novel and selective RORγ antagonist, which suppresses human TH17 cell differentiation at submicromolar concentrations. (±)-ML 209 has potential to treat TH17-related autoimmune diseases.
?您的位置：
